News & Alerts
-
Jan- 2024 -5 January
Nanoform’s Breakthrough: Game-Changing Prostate Cancer Pill Promises Daily Dose Revolution
Nanoform, the medicine performance-enhancing company based in Helsinki, Finland, has initiated a trial to assess the relative bioavailability of its…
Read More » -
4 January
FDA Warns Health Care Providers And Patients Not to Use Synovo Total Hip Resurfacing System
The U.S. Food and Drug Administration (FDA) has issued a safety communication warning healthcare providers and patients to avoid using…
Read More » -
4 January
BridGene Biosciences and Galapagos NV Join Forces in Landmark Collaboration for Oncology Drug Discovery
BridGene Biosciences, Inc., a trailblazer in small molecule drug discovery for challenging targets, has announced a strategic collaboration and licensing…
Read More » -
4 January
AbelZeta Pharma, Inc. Establishes Scientific Advisory Board to Propel Advancements in Inflammatory and Immunological Diseases
AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company specializing in the discovery and development of innovative cell-based therapeutic products, has…
Read More » -
4 January
Hi-Tech Pharmaceuticals Expands Production Capabilities to Revolutionize Dietary Supplements and OTC Drugs
Hi-Tech Pharmaceuticals, Inc., a leading global healthcare supplier, has announced a significant expansion in its manufacturing capabilities for dietary supplements…
Read More » -
4 January
Novartis Secures Groundbreaking $100 Million Deal with Voyager for Cutting-Edge Gene Therapy Partnership
On January 2, Voyager Therapeutics announced a significant licensing deal with Swiss-based drugmaker Novartis, wherein Novartis would make an upfront…
Read More » -
4 January
Glenmark Makes History: Unveils India’s First Biosimilar of Liraglutide, a Game-Changer in Diabetes Treatment
Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular10,11 anti-diabetic drug, Liraglutide, for the…
Read More » -
4 January
MediLink’s Global Pact with Roche Unveils Revolutionary Oncology Breakthrough
MediLink Therapeutics has recently unveiled a groundbreaking collaboration and license agreement with Roche, a leading pharmaceutical company, for the development…
Read More » -
3 January
US FDA Approvals Bounce Back In 2023, Sparking Hopes of a Biotech Recovery
The surge in U.S. Food and Drug Administration (FDA) approvals in 2023 has ignited optimism within the biotech industry, signaling…
Read More » -
2 January
Ascentage Pharma Takes Center Stage: CEO Dr. Dajun Yang to Unveil Innovations at 42nd J.P. Morgan Healthcare Conference
Ascentage Pharma, a global biopharmaceutical company specializing in novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, has…
Read More »